AbbVie Inc. · Q1 2022
ReportedApr 29, 2022
Period endedMar 31, 2022
Rule of 40+39
The quarter in short
Revenue $13.54B, up 4.1% year over year and down 9.1% on the quarter. EPS $2.51, up 26.1% year over year and 11.1% on the quarter. Free cash flow $4.75B, up 1.2% year over year and down 2.9% on the quarter. Rule of 40 score +39.
Reported this quarter
Revenue
$13.54B
QoQ −9.1%
YoY +4.1%
EPS
$2.51
QoQ +11.1%
YoY +26.1%
Free Cash Flow
$4.75B
QoQ −2.9%
YoY +1.2%
Gross Margin
70.1%
QoQ −0.9 pp
YoY +2.4 pp
FCF Margin
35.1%
QoQ +2.2 pp
YoY −1.0 pp
P/E Ratio
20.1
QoQ +11.9%
YoY −36.4%
Each tile opens the full quarterly series. Download the numbers as CSV or JSON.
Sources & downloads
Company
Published by the company on the day of the release.
HTML
Earnings press release
Investor relations announcement
SEC filings
Filed with the SEC under CIK 1551152.
HTML
8-K results announcement
Filed Apr 29, 2022
HTM
Press release (EX-99.1)
Exhibit 99.1 to the 8-K
260 KB
HTML
Filing index
Every document in the 8-K submission
TXT
Complete submission
Raw archival text of the whole filing
HTML
10-Q quarterly report
Period ended Mar 31, 2022, filed May 6, 2022
ZIP
XBRL data bundle
Structured financial statements from the 10-Q
JSON
Company facts (XBRL)
Every figure ABBV has reported to the SEC
R40 data
The numbers shown on this page, as we hold them.
CSV
This quarter (CSV)
Reported metrics for Q1 2022, spreadsheet-ready
JSON
This quarter (JSON)
Metrics, dates and matched filings